(Reuters) – Novavax Inc said on Tuesday the Drugs Controller General of India has granted emergency use authorization for its COVID-19 vaccine for adolescents aged 12 to 17 years in the country.
(Reporting by Manojna Maddipatla in Bengaluru; Editing by Shounak Dasgupta)
